Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-7-22
pubmed:abstractText
Pulmonary hypertension (PH) is a common complication of chronic hypoxic lung diseases, which increase morbidity and mortality. Hypoxic PH has previously been attributed to structural changes in the pulmonary vasculature including narrowing of the vascular lumen and loss of vessels, which produce a fixed increase in resistance. Using quantitative stereology, we now show that chronic hypoxia caused PH and remodeling of the blood vessel walls in rats but that this remodeling did not lead to structural narrowing of the vascular lumen. Sustained inhibition of the RhoA/Rho-kinase pathway throughout the period of hypoxic exposure attenuated PH and prevented remodeling in intra-acinar vessels without enlarging the structurally determined lumen diameter. In chronically hypoxic lungs, acute Rho kinase inhibition markedly decreased PVR but did not alter the alveolar to arterial oxygen gap. In addition to increased vascular resistance, chronic hypoxia induced Rho kinase-dependent capillary angiogenesis. Thus, hypoxic PH was not caused by fixed structural changes in the vasculature but by sustained vasoconstriction, which was largely Rho kinase dependent. Importantly, this vasoconstriction had no role in ventilation-perfusion matching and optimization of gas exchange. Rho kinase also mediated hypoxia-induced capillary angiogenesis, a previously unrecognized but potentially important adaptive response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1524-4571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
22
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
185-91
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15961717-Amides, pubmed-meshheading:15961717-Animals, pubmed-meshheading:15961717-Anoxia, pubmed-meshheading:15961717-Blood Pressure, pubmed-meshheading:15961717-Capillaries, pubmed-meshheading:15961717-Enzyme Inhibitors, pubmed-meshheading:15961717-Hypertension, Pulmonary, pubmed-meshheading:15961717-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:15961717-Lung, pubmed-meshheading:15961717-Male, pubmed-meshheading:15961717-Neovascularization, Physiologic, pubmed-meshheading:15961717-Oxygen Consumption, pubmed-meshheading:15961717-Protein-Serine-Threonine Kinases, pubmed-meshheading:15961717-Pyridines, pubmed-meshheading:15961717-Rats, pubmed-meshheading:15961717-Vascular Endothelial Growth Factor A, pubmed-meshheading:15961717-Vascular Resistance, pubmed-meshheading:15961717-Vasoconstriction, pubmed-meshheading:15961717-rho-Associated Kinases, pubmed-meshheading:15961717-rhoA GTP-Binding Protein
pubmed:year
2005
pubmed:articleTitle
Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation.
pubmed:affiliation
Department of Physiology, University College, Earlsfort Terrace, Dublin 2, Ireland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't